Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Edward Soltesz

Thoracic Surgery (Cardiothoracic Vascular Surgery) Cleveland, OH Medical Doctor

NPI 1629015730 CMS profile 27741

9500 Euclid Ave, Cleveland, OH 44195

Open in the dashboard

General payments

$835,038

804 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$338,085 paid to institutions, not to them · program years 2019–2024

Through program year 2025, Edward Soltesz of Cleveland, OH is reported in the CMS Open Payments database as having received $835,038 across 804 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $338,085 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $112,163 95
2024 General $177,702 115
2023 General $154,117 148
2022 General $125,338 137
2021 General $84,266 88
2020 General $75,501 69
2019 General $105,950 152

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Edward Soltesz
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Edward Soltesz were reported at $112,163. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Edward Soltesz Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $105,950 $886 $178–$3,167 $163
2020 $75,501 $341 $108–$1,605 $114
2021 $84,266 $453 $125–$1,886 $132
2022 $125,338 $695 $180–$2,566 $149
2023 $154,117 $745 $205–$2,662 $160
2024 $177,702 $799 $214–$2,967 $164
2025 $112,163 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Abiomed $375,868 271 payments
  2. Abbott Laboratories $236,469 228 payments
  3. Atricure, Inc. $181,936 246 payments
  4. Edwards Lifesciences Corporation $25,767 25 payments
  5. Dilon Technologies, Inc. $13,691 14 payments
  6. JACE Medical LLC $499 2 payments
  7. Corcym Inc $200 3 payments
  8. Biom'Up SA $134 1 payment
  9. Medtronic, Inc. $94 3 payments
  10. Medtronic Vascular, Inc. $90 3 payments
  11. Other $289 8 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $354,380 130 payments
  2. Honoraria $293,750 78 payments
  3. Travel and Lodging $78,385 270 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $57,000 16 payments
  5. Compensation for serving as faculty or as a speaker for a medical education program $27,188 5 payments
  6. Food and Beverage $18,336 302 payments
  7. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $6,000 3 payments
Products named General payments · program years 2019–2025
  1. Impella $340,485 241 payments
  2. SYNERGY ABLATION SYSTEM $116,164 167 payments
  3. EPIC $75,034 54 payments
  4. EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX $42,332 40 payments
  5. HeartMate 3 Left Ventricular Dev $39,311 57 payments
  6. AtriCure cryoICE cryoSPHERE Cryoablation System $33,758 49 payments
  7. ATRICLIP LAA EXCLUSION SYSTEM $27,587 57 payments
  8. MITRACLIP $23,842 5 payments
  9. Trifecta GT Tissue Heart Valve $21,179 16 payments
  10. THORATEC HEARTMATE 3 LVAS IMPLANT KIT $19,015 24 payments
  11. Other $90,706 138 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 61 billing codes

Paid by Medicare

$227,271

Medicare's payments for the services billed

Medicare patients

119

Average age 72

Services billed

350

42 women, 77 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 75%
Atrial fibrillation 71%
Heart failure 53%
Chronic kidney disease 40%
Arthritis 33%
Diabetes 31%
COPD 29%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

804 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Thoracic Surgery (Cardiothoracic Vascular Surgery) in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record